LNAI - Enochian Biosciences Inc
0.2322
-0.129 -55.685%
Share volume: 989,953
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.36
-0.13
-0.36%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 08-20-2024 | 01-07-2025 | 02-19-2025 | 02-19-2025 | 05-15-2025 | 11-14-2025 | 02-17-2026 | |
| Assets | ||||||||
| Total Assets | 178.089 M | 163.129 M | 121.833 M | 111.340 M | 117.726 M | 6.961 M | 6.666 M | |
| Current Assets | 1.220 M | 1.998 M | 1.948 M | 1.708 M | 3.668 M | 800.360 K | 514.489 K | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 1.108 M | 1.242 M | 127.080 K | 127.080 K | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 710.281 K | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 312.697 K | 220.467 K | 220.571 K | 311.764 K | 923.002 K | 624.808 K | 491.645 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 488.915 K | 482.121 K | 452.212 K | 422.032 K | 393.119 K | 12.465 K | 13.253 K | |
| Other Assets | 176.381 M | 160.650 M | 119.432 M | 109.210 M | 113.665 M | 6.148 M | 6.139 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 178.089 M | 163.129 M | 121.833 M | 111.340 M | 117.726 M | 6.961 M | 6.666 M | |
| Total liabilities | 43.684 M | 31.152 M | 23.746 M | 29.281 M | 29.339 M | 20.001 M | 20.215 M | |
| Total current liabilities | 20.874 M | 30.310 M | 23.035 M | 28.607 M | 28.842 M | 19.722 M | 20.002 M | |
| Accounts Payable | 7.991 M | 9.449 M | 11.402 M | 10.935 M | 11.726 M | 12.094 M | 12.340 M | |
| Other liabilities | 20.035 M | 842.389 K | 710.260 K | 674.200 K | 497.629 K | 278.963 K | 213.657 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 120.000 K | |
| Other liabilities | 20.035 M | 842.389 K | 710.260 K | 674.200 K | 497.629 K | 278.963 K | 213.657 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 134.406 M | 131.977 M | 98.087 M | 82.059 M | 88.387 M | -13.041 M | -13.549 M | |
| Common stock | 442.319 M | 456.827 M | 468.457 M | 469.826 M | 471.342 M | 494.731 M | 496.033 M | |
| Retained earnings | -308.948 M | -324.679 M | -376.667 M | -383.920 M | -383.730 M | -507.644 M | -509.443 M |